Last updated 10 September 22
My Google Scholar profile can be found here.
- Name: Dr. Janick Weberpals
- Current affiliation: Harvard Medical School and Brigham and Women’s Hospital
- Citations total: 542 citations (details on publications can be found in Publications
- h-index: 12
- i10-index: 14
Citations and impact factors
Citations per year
Cumulative citations
Cumulative impact factor publications by year
Top cited articles
My top 5 cited articles are listed below. The impact factor relates to the year of publication. A more detailed list on publications can be found in Report of Scholarship below.
Full citation | # citations | Journal impact factor |
Muhlack DC, Hoppe LK, Weberpals J, Brenner H, Schöttker B. The Association of Potentially Inappropriate Medication at Older Age With Cardiovascular Events and Overall Mortality: A Systematic Review and Meta-Analysis of Cohort Studies. J Am Med Dir Assoc. 2017 Mar 1;18(3):211-20. doi: 10.1016/j.jamda.2016.11.025. Epub 2017 Jan 26. PMID: 28131719. | 107 | 5.325 |
Weberpals J, Jansen L, Müller OJ, Brenner H. Long-term heart-specific mortality among 347 476 breast cancer patients treated with radiotherapy or chemotherapy: a registry-based cohort study. Eur Heart J. 2018 Nov 14;39(43):3896-903. doi: 10.1093/eurheartj/ehy167. PMID: 29635274. | 77 | 24.889 |
Weberpals J, Jansen L, Carr PR, Hoffmeister M, Brenner H. Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis. Cancer Treat Rev. 2016 Jun;47:1-11. doi: 10.1016/j.ctrv.2016.04.004. Epub 2016 Apr 26. PMID: 27179912. | 74 | 8.589 |
Carr PR*, Alwers E*, Bienert S, Weberpals J, Kloor M, Brenner H, Hoffmeister M. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses. Ann Oncol. 2018 Apr 1;29(4):825-34. doi: 10.1093/annonc/mdy059. PMID: 29438474. | 62 | 14.196 |
Weberpals J, Jansen L, van Herk-Sukel MPP, Kuiper JG, Aarts MJ, Vissers PAJ, Brenner H. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis. Eur J Epidemiol. 2017 Nov;32(11):1019-31. doi: 10.1007/s10654-017-0304-5. Epub 2017 Sep 1. PMID: 28864947. | 32 | 7.023 |
Co-author network
